|
🐜
|
An official American Thoracic Society/European Respiratory Society statement: Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias.
36 auth.
W. Travis,
U. Costabel,
D. Hansell,
T. King,
D. Lynch,
A. Nicholson,
C. Ryerson,
J. Ryu,
M. Selman,
A. Wells,
J. Behr,
D. Bouros,
K. Brown,
T. Colby,
H. Collard,
...
C. Cordeiro,
V. Cottin,
B. Crestani,
M. Drent,
R. Dudden,
J. Egan,
K. Flaherty,
C. Hogaboam,
Y. Inoue,
T. Johkoh,
D. S. Kim,
M. Kitaichi,
J. Loyd,
Fernando J. Martinez,
J. Myers,
Shandra L. Protzko,
G. Raghu,
L. Richeldi,
N. Sverzellati,
J. Swigris,
D. Valeyre
|
11 |
2013 |
11
🐜
|
|
🐜
|
Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline
34 auth.
G. Raghu,
M. Rémy-Jardin,
J. Myers,
L. Richeldi,
C. Ryerson,
D. Lederer,
J. Behr,
V. Cottin,
S. Danoff,
F. Morell,
K. Flaherty,
A. Wells,
F. Martinez,
A. Azuma,
T. Bice,
...
Demosthenes Bouros,
K. Brown,
H. Collard,
A. Duggal,
L. Galvin,
Y. Inoue,
R. Jenkins,
T. Johkoh,
E. Kazerooni,
M. Kitaichi,
S. Knight,
G. Mansour,
A. Nicholson,
S. Pipavath,
I. Buendía-Roldán,
M. Selman,
W. Travis,
S. Walsh,
K. Wilson
|
11 |
2018 |
11
🐜
|
|
🐜
|
Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis.
23 auth.
L. Richeldi,
R. D. du Bois,
G. Raghu,
A. Azuma,
K. Brown,
U. Costabel,
V. Cottin,
K. Flaherty,
D. Hansell,
Y. Inoue,
...
D. S. Kim,
M. Kolb,
A. Nicholson,
P. Noble,
M. Selman,
H. Taniguchi,
M. Brun,
F. Le Maulf,
M. Girard,
S. Stowasser,
R. Schlenker‐Herceg,
B. Disse,
H. Collard
|
10 |
2014 |
10
🐜
|
|
🐜
|
Survival in Patients With Idiopathic, Familial, and Anorexigen-Associated Pulmonary Arterial Hypertension in the Modern Management Era
22 auth.
M. Humbert,
O. Sitbon,
A. Chaouat,
M. Bertocchi,
G. Habib,
V. Gressin,
A. Yaïci,
E. Weitzenblum,
J. Cordier,
F. Chabot,
...
C. Dromer,
C. Pison,
M. Reynaud‐Gaubert,
A. Haloun,
M. Laurent,
E. Hachulla,
V. Cottin,
B. Degano,
X. Jaïs,
D. Montani,
R. Souza,
G. Simonneau
|
10 |
2010 |
10
🐜
|
|
🐜
|
Nintedanib in Progressive Fibrosing Interstitial Lung Diseases.
18 auth.
K. Flaherty,
A. Wells,
V. Cottin,
A. Devaraj,
S. Walsh,
Y. Inoue,
L. Richeldi,
M. Kolb,
K. Tetzlaff,
S. Stowasser,
...
C. Coeck,
E. Clerisme-Beaty,
B. Rosenstock,
M. Quaresma,
T. Haeufel,
R. Goeldner,
R. Schlenker‐Herceg,
K. Brown
|
10 |
2019 |
10
🐜
|
|
🐜
|
International guidelines for the diagnosis and management of hereditary haemorrhagic telangiectasia
33 auth.
M. Faughnan,
V. Palda,
G. Garcia‐Tsao,
U. Geisthoff,
J. McDonald,
D. Proctor,
J. Spears,
Dale H. Brown,
E. Buscarini,
M. Chesnutt,
V. Cottin,
A. Ganguly,
J. Gossage,
A. Guttmacher,
R. Hyland,
...
S. Kennedy,
J. Korzenik,
J. Mager,
A. Ozanne,
J. Piccirillo,
D. Picus,
H. Plauchu,
M. Porteous,
R. Pyeritz,
D. Ross,
C. Sabbà,
K. Swanson,
Peter B. Terry,
M. Wallace,
C. Westermann,
R. White,
L. Young,
R. Zarrabeitia
|
9 |
2009 |
9
🐜
|
|
🦁
|
Combined pulmonary fibrosis and emphysema: a distinct underrecognised entity
10 auth.
V. Cottin,
H. Nunes,
P. Brillet,
P. Delaval,
G. Devouassoux,
I. Tillie‐Leblond,
...
D. Israel‐Biet,
I. Court-Fortune,
D. Valeyre,
J. Cordier
|
9 |
2005 |
9
🦁
|
|
🐢
|
An official European Respiratory Society/American Thoracic Society research statement: interstitial pneumonia with autoimmune features
19 auth.
A. Fischer,
K. Antoniou,
K. Brown,
J. Cadranel,
T. Corte,
R. D. du Bois,
Joyce S. Lee,
K. Leslie,
D. Lynch,
E. Matteson,
...
M. Mosca,
I. Noth,
L. Richeldi,
M. Strek,
J. Swigris,
A. Wells,
S. West,
H. Collard,
V. Cottin
|
9 |
2015 |
9
🐢
|
|
🐜
|
Pulmonary hypertension due to left heart diseases.
15 auth.
J. Vachiéry,
Y. Adir,
J. Barberà,
H. Champion,
J. G. Coghlan,
V. Cottin,
T. De Marco,
N. Galiè,
S. Ghio,
J. Gibbs,
...
F. Martinez,
M. Semigran,
G. Simonneau,
A. Wells,
W. Seeger
|
9 |
2013 |
9
🐜
|
|
🐜
|
Risk assessment, prognosis and guideline implementation in pulmonary arterial hypertension
18 auth.
A. Boucly,
J. Weatherald,
L. Savale,
X. Jaïs,
V. Cottin,
G. Prévôt,
F. Picard,
P. De Groote,
M. Jevnikar,
E. Bergot,
...
A. Chaouat,
C. Chabanne,
A. Bourdin,
F. Parent,
D. Montani,
G. Simonneau,
M. Humbert,
O. Sitbon
|
9 |
2017 |
9
🐜
|
|
🐜
|
European Respiratory Society guidelines for the diagnosis and management of lymphangioleiomyomatosis
13 auth.
S. Johnson,
J. Cordier,
R. Lazor,
R. Lazor,
V. Cottin,
U. Costabel,
S. Harari,
M. Reynaud‐Gaubert,
A. Boehler,
M. Brauner,
...
H. Popper,
F. Bonetti,
C. Kingswood
|
8 |
2010 |
8
🐜
|
|
🦁
|
Presentation, diagnosis and clinical course of the spectrum of progressive-fibrosing interstitial lung diseases
11 auth.
V. Cottin,
N. Hirani,
D. Hotchkin,
A. Nambiar,
T. Ogura,
M. Otaola,
...
D. Skowasch,
Jong Sun Park,
Hataya K. Poonyagariyagorn,
W. Wuyts,
A. Wells
|
8 |
2018 |
8
🦁
|
|
🦁
|
Pulmonary hypertension in patients with combined pulmonary fibrosis and emphysema syndrome
8 auth.
V. Cottin,
J. Pavec,
G. Prévôt,
H. Mal,
M. Humbert,
G. Simonneau,
...
J. Cordier,
Germ“O”P
|
8 |
2009 |
8
🦁
|
|
🐢
|
Pirfenidone in patients with unclassifiable progressive fibrosing interstitial lung disease: a double-blind, randomised, placebo-controlled, phase 2 trial.
11 auth.
T. Maher,
T. Corte,
A. Fischer,
M. Kreuter,
D. Lederer,
M. Molina-Molina,
...
J. Axmann,
K. Kirchgaessler,
K. Samara,
F. Gilberg,
V. Cottin
|
8 |
2020 |
8
🐢
|
